A single-center retrospective evaluation of the use of oral factor Xa inhibitors in patients with cerebral venous thrombosis
M Powell, K Tremolet de Villers… - Annals of …, 2021 - journals.sagepub.com
Background: Clinical practice guidelines recommend that cerebral venous thrombosis (CVT)
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis.
M Powell, K Tremolet de Villers… - Annals of …, 2021 - search.ebscohost.com
Background: Clinical practice guidelines recommend that cerebral venous thrombosis (CVT)
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis
M Powell, KT de Villers, K Schwarz… - The Annals of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Clinical practice guidelines recommend that cerebral venous thrombosis (CVT)
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis.
M Powell, K Tremolet de Villers, K Schwarz… - The Annals of …, 2020 - europepmc.org
Background Clinical practice guidelines recommend that cerebral venous thrombosis (CVT)
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …
be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight …